PD-1, CTLA-4, and their ligands, have been shown to be upregulated on T cells during sepsis, which has led to investigations on immune checkpoint inhibition also as immunomodulatory treatment in infections [13, 14]. The gene discussed is CTLA4; the disease is Sepsis.